Stawicki Stanislaw Peter, El Chaar Maher, Baillie Daniel R, Jaik Nikhil P, Estrada Fernando P
Opus 12 Foundation, King of Prussia, PA 19406, USA.
Nucl Med Rev Cent East Eur. 2007;10(2):82-6.
Sestamibi imaging is the most widely used preoperative localization study for patients with hyperparathyroidism. Previous reports examine the relationship between the weight and volume of excised parathyroid glands and preoperative serum calcium and parathyroid hormone (PTH) levels. The aim of this study was to examine whether these variables correlate with the results of preoperative Sestamibi scans.
A retrospective review of 150 consecutive patients who underwent preoperative sestamibi imaging for primary hyperparathyroidism between 1998 and 2007 was performed. Variables studied included patient demographics, diagnostic test (sestamibi) results, operative/pathology findings and surgical outcome (normocalcaemia vs. persistent hypercalcaemia). Sestamibi scans were designated as either "negative" (NSS) or "positive" (PSS), where PSS correctly localized abnormal gland(s) enabling a focused neck exploration. The results of sestamibi imaging were correlated with calcium/PTH levels, weight/volume of excised glands and patient outcomes and demographics.
Total excised gland weight/volume and preoperative serum calcium levels were significantly higher with PSS (all, p < 0.04). Higher preoperative serum calcium levels and greater total gland weight/volume were significantly associated with successful operative outcome (presence of postoperative normocalcaemia; all, p < 0.01). Factors associated with operative failure included multi-gland disease (p < 0.01) and NSS (p < < 0.01). Higher diagnostic PTH levels (> 150 pg/mL) were associated with greater excised gland mass (p < 0.05) and volume (p < 0.05). Male gender was associated with higher preoperative serum calcium levels (p < 0.02). Of interest, patients with single-gland disease had significantly higher preoperative PTH levels than patients with multi-gland disease (155 vs. 109 pg/mL, p < 0.05).
Positive sestamibi scans are associated with heavier/larger parathyroid glands and higher preoperative serum calcium levels. Male gender was associated with higher preoperative serum calcium levels, while single-gland disease was associated with higher preoperative PTH levels. In addition, successful surgical outcome was associated with higher preoperative serum calcium levels and with greater excised parathyroid gland mass/volume. Surgical failure was associated with multi-gland disease and negative sestamibi.
对于甲状旁腺功能亢进患者,锝[99mTc]甲氧基异丁基异腈显像(Sestamibi显像)是术前最广泛使用的定位检查。既往报告研究了切除的甲状旁腺重量和体积与术前血清钙及甲状旁腺激素(PTH)水平之间的关系。本研究的目的是检验这些变量是否与术前Sestamibi扫描结果相关。
对1998年至2007年间连续150例行原发性甲状旁腺功能亢进术前Sestamibi显像的患者进行回顾性研究。研究变量包括患者人口统计学资料、诊断检查(Sestamibi)结果、手术/病理结果及手术结局(血钙正常与持续性高钙血症)。Sestamibi扫描分为“阴性”(NSS)或“阳性”(PSS),其中PSS能正确定位异常腺体,从而可行有针对性的颈部探查。将Sestamibi显像结果与钙/PTH水平、切除腺体的重量/体积、患者结局及人口统计学资料进行相关性分析。
PSS组切除腺体的总重量/体积及术前血清钙水平显著更高(均为p < 0.04)。术前血清钙水平较高及切除腺体的总重量/体积较大与手术成功结局(术后血钙正常;均为p < 0.01)显著相关。与手术失败相关的因素包括多腺体疾病(p < 0.01)和NSS(p << 0.01)。诊断性PTH水平较高(> 150 pg/mL)与切除腺体的更大质量(p < 0.05)和体积(p < 0.05)相关。男性与术前血清钙水平较高相关(p < 0.02)。有趣的是,单腺体疾病患者的术前PTH水平显著高于多腺体疾病患者(155 vs. 109 pg/mL,p < 0.05)。
Sestamibi扫描阳性与甲状旁腺腺体更重/更大及术前血清钙水平较高相关。男性与术前血清钙水平较高相关,而单腺体疾病与术前PTH水平较高相关。此外,手术成功结局与术前血清钙水平较高及切除的甲状旁腺腺体更大质量/体积相关。手术失败与多腺体疾病和Sestamibi扫描阴性相关。